From Niche to Necessity:The Menopause Market’s Next Chapter

Overview

How the menopause market is maturing: new diagnostics, precision care, shifting investment patterns, and a changing narrative

The menopause market has matured rapidly – but the most interesting chapter may be just beginning. Join Femtech Insider Founder & CEO Kathrin Folkendt for an in-depth look at how menopause diagnostics and care are evolving, where investors are placing bets, and what the next wave of innovation looks like.

About this Event

Just a few years ago, menopause startups struggled to raise a seed round. Investors called the space “niche.” Today, the landscape looks fundamentally different. Menopause is being reframed as a serious medical and longevity inflection point, new treatments are reaching the market, the FDA has removed its decades-old black box warning on hormone therapy, and countries are publishing their first-ever clinical guidelines on menopause care.

But as the market matures, the questions are shifting too.

We’re moving beyond first-generation symptom trackers and telehealth platforms toward precision diagnostics, biomarker-driven care, and deeper integration with clinical pathways.

Meanwhile, the connection between menopause and long-term cardiovascular, cognitive, and bone health is reshaping how the entire space is understood – by clinicians, investors, and women themselves.

In this upcoming session, we’ll explore:

• Market Evolution: How the menopause innovation landscape has changed
• Diagnostics & Biomarkers: What’s happening in hormonal monitoring, wearable-driven insights, and AI-powered tools
• Novel Treatments: New therapies, the impact of the updated HRT safety narrative, and where pharma and startups are converging
• Investment Patterns: Where capital is flowing, which segments are attracting the most attention, and what consolidation in the space means for founders and investors
• The Bigger Picture: How menopause is being repositioned at the intersection of women’s health, brain health, cardiovascular risk, and longevity – and why that matters for the entire sector

Why Attend?

• Understand how the menopause market has evolved and where the big opportunities lie right now
• Get up to speed on emerging diagnostics and precision care approaches
• Learn how regulatory and narrative shifts are opening up new categories of innovation
• Identify where investors are placing bets – and where the gaps remain
• Connect the dots between menopause care and the broader longevity and women’s health agendas

This session is ideal for investors exploring the menopause and midlife health opportunity, founders building in this space, healthcare professionals integrating menopause care into practice, and anyone tracking the evolution of women’s health innovation.

Femtech Insider Inner Circle Members attend this event for free. A recording will be shared with all who register.

About Femtech Insider

Femtech Insider is the leading platform for femtech and women’s health innovation, connecting professionals across the industry through information, education, analysis, and events.